CRL-2238 SNU-423 人肝细胞癌

CRL-2238 SNU-423 人肝细胞癌

收藏
  • 询价
  • ATCC中国传代
  • SNU-423
  • 2025年12月14日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 询价记录
    • 技术资料
    • 供应商

      复祥生物

    • 肿瘤类型

      查询相关资料

    • 细胞类型

      查询相关资料

    • 品系

      查询相关资料

    • 相关疾病

      查询相关资料

    • 物种来源

    • 免疫类型

      查询相关资料

    • 细胞形态

      查询相关资料

    • 器官来源

    • 运输方式

      常温或干冰

    • 生长状态

      正常

    • 库存

      大量

    CRL-2238 SNU-423 人肝细胞癌,原代细胞|细胞系|细胞株|菌种;细胞库管理规范,提供的细胞株背景清楚,提供参考文献和最优培养条件!

    CRL-2238 SNU-423 人肝细胞癌 的详细介绍
    CRL-2238 SNU-423 人肝细胞
    ATCC® Number: CRL-2238™ Price: $417.00
    Designations: SNU-423
    Depositors: J Park
    Biosafety Level: 2 [CELLS CONTAIN HEPATITIS B VIRUS ]
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens (human)
    Morphology: epithelial
    Source: Organ: liver
    Tumor Stage: grade III/IV
    Disease: pleomorphic hepatocellular carcinoma
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Antigen Expression: Blood Type B; Rh +
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 11,12
    D13S317: 10,13
    D16S539: 9
    D5S818: 10
    D7S820: 12
    THO1: 6,9
    TPOX: 8
    vWA: 15
    Cytogenetic Analysis: aneuploid; modal number = 79
    Age: 40 years
    Gender: male
    Ethnicity: Asian
    Comments: SNU-423 was derived in 1990 by J.-G. Park and associates from a primary hepatocellular carcinoma taken from a Korean patient who had been treated by transcatheter arterial embolization with lipoidol plus doxorubicin.
    Tumor cells were initially cultured in ACL-4 medium supplemented with 5% heat-inactivated fetal bovine serum.
    After establishment, cultures were maintained in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum.
    Grossly, the original tumor was single nodular with perinodular extensions.
    Histologically, it was trabecular type.
    The cultured cells are multinucleated.
    Hepatitis B virus (HBV) DNA was detected by Southern blot hybridization.
    HBV genomic RNA was not expressed.
    Propagation: ATCC complete growth medium: RPMI 1640 medium, 90%; heat-inactivated fetal bovine serum, 10%
    Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:5 is recommended
    Medium Renewal: Every 2 to 3 days
    Remove spent medium, add fresh 0.25% trypsin, 0.03% EDTA solution, rinse and remove trypsin.
    Add fresh trypsin solution (1 to 2 ml) and let the culture sit at room temperature (or at 37C) until the cells detach.
    Preservation: Culture medium, 95%; DMSO, 5%
    Doubling Time: 72 hrs
    References: 22872: Park JG, et al. Characterization of cell lines established from human hepatocellular carcinoma. Int. J. Cancer 62: 276-282, 1995. PubMed: 7543080
    ATCC® Number: CRL-2238™ Price: $417.00
    Designations: SNU-423
    Depositors: J Park
    Biosafety Level: 2 [CELLS CONTAIN HEPATITIS B VIRUS ]
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens (human)
    Morphology: epithelial


    Source: Organ: liver
    Tumor Stage: grade III/IV
    Disease: pleomorphic hepatocellular carcinoma
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

    Antigen Expression: Blood Type B; Rh +
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 11,12
    D13S317: 10,13
    D16S539: 9
    D5S818: 10
    D7S820: 12
    THO1: 6,9
    TPOX: 8
    vWA: 15
    Cytogenetic Analysis: aneuploid; modal number = 79
    Age: 40 years
    Gender: male
    Ethnicity: Asian
    Comments: SNU-423 was derived in 1990 by J.-G. Park and associates from a primary hepatocellular carcinoma taken from a Korean patient who had been treated by transcatheter arterial embolization with lipoidol plus doxorubicin.
    Tumor cells were initially cultured in ACL-4 medium supplemented with 5% heat-inactivated fetal bovine serum.
    After establishment, cultures were maintained in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum.
    Grossly, the original tumor was single nodular with perinodular extensions.
    Histologically, it was trabecular type.
    The cultured cells are multinucleated.
    Hepatitis B virus (HBV) DNA was detected by Southern blot hybridization.
    HBV genomic RNA was not expressed.
    Propagation: ATCC complete growth medium: RPMI 1640 medium, 90%; heat-inactivated fetal bovine serum, 10%

    Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:5 is recommended
    Medium Renewal: Every 2 to 3 days
    Remove spent medium, add fresh 0.25% trypsin, 0.03% EDTA solution, rinse and remove trypsin.
    Add fresh trypsin solution (1 to 2 ml) and let the culture sit at room temperature (or at 37C) until the cells detach.
    Preservation: Culture medium, 95%; DMSO, 5%
    Doubling Time: 72 hrs
    References: 22872: Park JG, et al. Characterization of cell lines established from human hepatocellular carcinoma. Int. J. Cancer 62: 276-282, 1995. PubMed: 7543080


    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥800
    上海信裕生物科技有限公司
    2025年06月01日询价
    ¥800
    上海再康生物科技有限公司
    2025年11月20日询价
    ¥2500
    上海酶研生物科技有限公司
    2025年08月13日询价
    ¥800
    上海康朗生物科技有限公司
    2025年12月08日询价
    CRL-2238 SNU-423 人肝细胞癌
    询价